Patents by Inventor William Wyatt

William Wyatt has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11980842
    Abstract: Disclosed in certain embodiments are sorbents for capturing heavy hydrocarbons via thermal swing adsorption processes.
    Type: Grant
    Filed: February 21, 2022
    Date of Patent: May 14, 2024
    Assignee: BASF Corporation
    Inventors: William B. Dolan, Roger Wyatt, Angela Siegel, Klaus Neumann, Tobias Eckardt
  • Publication number: 20220403452
    Abstract: Provided are methods for profiling cellular analytes of a cell by barcoding the cell in a combinatorial split and pool iterative process. In some instances, a cell bead may be generated from the cell, and the analytes therein barcoded in a combinatorial split and pool iterative process while the analytes are retained in the cell bead during iterative partitioning.
    Type: Application
    Filed: March 4, 2022
    Publication date: December 22, 2022
    Inventors: Shea T. Lance, Geoffrey McDermott, Paul William Wyatt, Daniel P. Riordan, Michael Schnall-Levin
  • Patent number: 11414688
    Abstract: This disclosure provides methods for preparing a sequencing library including the steps of providing a template nucleic acid sequence, dNTPs, dUTP, a primer, a polymerase, a dUTP excising enzyme, and a plurality of beads including oligonucleotide adapter sequence segments; amplifying the template nucleic acid with the polymerase, dNTPs, dUTP and random hexamer to provide a complementary nucleic acid sequence including occasional dUTPs; and excising the incorporated dUTPs with the dUTP excising enzyme to provide nicks in the complementary nucleic acid sequence to provide a sequencing library.
    Type: Grant
    Filed: December 17, 2019
    Date of Patent: August 16, 2022
    Assignee: 10X GENOMICS, INC.
    Inventors: Paul Hardenbol, Pranav Patel, Benjamin Hindson, Paul William Wyatt, Keith Bjornson, Indira Wu, Zahra Kamila Belhocine
  • Patent number: 11286193
    Abstract: A submerged combustion melting system includes a submerged combustion melter having a housing that defines a melting chamber and one or more vibration damping devices operatively coupled to the housing.
    Type: Grant
    Filed: June 20, 2019
    Date of Patent: March 29, 2022
    Assignee: Owens Corning Intellectual Capital, LLC
    Inventors: Steven James Mighton, William Wyatt Toth, Alvin Lee Miller, Bruno Andre Purnode
  • Publication number: 20200190551
    Abstract: This disclosure provides methods for preparing a sequencing library including the steps of providing a template nucleic acid sequence, dNTPs, dUTP, a primer, a polymerase, a dUTP excising enzyme, and a plurality of beads including oligonucleotide adapter sequence segments; amplifying the template nucleic acid with the polymerase, dNTPs, dUTP and random hexamer to provide a complementary nucleic acid sequence including occasional dUTPs; and excising the incorporated dUTPs with the dUTP excising enzyme to provide nicks in the complementary nucleic acid sequence to provide a sequencing library.
    Type: Application
    Filed: December 17, 2019
    Publication date: June 18, 2020
    Inventors: Paul Hardenbol, Pranav Patel, Benjamin Hindson, Paul William Wyatt, Keith Bjornson, Indira Wu, Zahra Kamila Belhocine
  • Patent number: 10557118
    Abstract: Compositions and methods are provided for preventing or treating neoplastic disease in a mammalian subject. A composition is provided which comprises an enriched immune cell population reactive to a human endogenous retrovirus type E antigen on a tumor cell. A method of treating a neoplastic disease in a mammalian subject is provided which comprises administering to a mammalian subject a composition comprising an enriched immune cell population reactive to a human endogenous retrovirus type E antigen, in an amount effective to reduce or eliminate the neoplastic disease or to prevent its occurrence or recurrence.
    Type: Grant
    Filed: January 7, 2019
    Date of Patent: February 11, 2020
    Assignee: The Government of the United States of America, as represented by the Secretary, Department of Health and Human Services
    Inventors: Richard William Wyatt Childs, Yoshiyuki Takahashi, Sachiko Kajigaya, Nanae Harashima
  • Patent number: 10557158
    Abstract: This disclosure provides methods for preparing a sequencing library including the steps of providing a template nucleic acid sequence, dNTPs, dUTP, a primer, a polymerase, a dUTP excising enzyme, and a plurality of beads including oligonucleotide adapter sequence segments; amplifying the template nucleic acid with the polymerase, dNTPs, dUTP and random hexamer to provide a complementary nucleic acid sequence including occasional dUTPs; and excising the incorporated dUTPs with the dUTP excising enzyme to provide nicks in the complementary nucleic acid sequence to provide a sequencing library.
    Type: Grant
    Filed: December 20, 2018
    Date of Patent: February 11, 2020
    Assignee: 10X GENOMICS, INC.
    Inventors: Paul Hardenbol, Pranav Patel, Benjamin Hindson, Paul William Wyatt, Keith Bjornson, Indira Wu, Kamila Belhocine
  • Publication number: 20190300415
    Abstract: A submerged combustion melting system includes a submerged combustion melter having a housing that defines a melting chamber and one or more vibration damping devices operatively coupled to the housing.
    Type: Application
    Filed: June 20, 2019
    Publication date: October 3, 2019
    Inventors: Steven James Mighton, William Wyatt Toth, Alvin Lee Miller, Bruno Andre Purnode
  • Patent number: 10370278
    Abstract: A submerged combustion melting system (90) includes a submerged combustion melter (100) having a housing (102) that defines a melting chamber (104) and one or more vibration damping devices (340) operatively coupled to the housing (102).
    Type: Grant
    Filed: June 24, 2016
    Date of Patent: August 6, 2019
    Assignee: OCV Intellectual Capital, LLC
    Inventors: Steven James Mighton, William Wyatt Toth, Alvin Lee Miller, Bruno Andre Purnode
  • Publication number: 20190169666
    Abstract: This disclosure provides methods for preparing a sequencing library including the steps of providing a template nucleic acid sequence, dNTPs, dUTP, a primer, a polymerase, a dUTP excising enzyme, and a plurality of beads including oligonucleotide adapter sequence segments; amplifying the template nucleic acid with the polymerase, dNTPs, dUTP and random hexamer to provide a complementary nucleic acid sequence including occasional dUTPs; and excising the incorporated dUTPs with the dUTP excising enzyme to provide nicks in the complementary nucleic acid sequence to provide a sequencing library.
    Type: Application
    Filed: December 20, 2018
    Publication date: June 6, 2019
    Inventors: Paul Hardenbol, Pranav Patel, Benjamin Hindson, Paul William Wyatt, Keith Bjornson, Indira Wu, Kamila Belhocine
  • Publication number: 20190127695
    Abstract: Compositions and methods are provided for preventing or treating neoplastic disease in a mammalian subject. A composition is provided which comprises an enriched immune cell population reactive to a human endogenous retrovirus type E antigen on a tumor cell. A method of treating a neoplastic disease in a mammalian subject is provided which comprises administering to a mammalian subject a composition comprising an enriched immune cell population reactive to a human endogenous retrovirus type E antigen, in an amount effective to reduce or eliminate the neoplastic disease or to prevent its occurrence or recurrence.
    Type: Application
    Filed: January 7, 2019
    Publication date: May 2, 2019
    Applicant: The Government of the USA, as represented by the Secretary, Dept. of Health and Human Services
    Inventors: Richard William Wyatt Childs, Yoshiyuki Takahashi, Sachiko Kajigaya, Nanae Harashima
  • Patent number: 10221436
    Abstract: This disclosure provides methods for preparing a sequencing library including the steps of providing a template nucleic acid sequence, dNTPs, dUTP, a primer, a polymerase, a dUTP excising enzyme, and a plurality of beads including oligonucleotide adapter sequence segments; amplifying the template nucleic acid with the polymerase, dNTPs, dUTP and random hexamer to provide a complementary nucleic acid sequence including occasional dUTPs; and excising the incorporated dUTPs with the dUTP excising enzyme to provide nicks in the complementary nucleic acid sequence to provide a sequencing library.
    Type: Grant
    Filed: January 7, 2016
    Date of Patent: March 5, 2019
    Assignee: 10X GENOMICS, INC.
    Inventors: Paul Hardenbol, Pranav Patel, Benjamin Hindson, Paul William Wyatt, Keith Bjornson, Indira Wu, Kamila Belhocine
  • Patent number: 10214726
    Abstract: Compositions and methods are provided for preventing or treating neoplastic disease in a mammalian subject. A composition is provided which comprises an enriched immune cell population reactive to a human endogenous retrovirus type E antigen on a tumor cell. A method of treating a neoplastic disease in a mammalian subject is provided which comprises administering to a mammalian subject a composition comprising an enriched immune cell population reactive to a human endogenous retrovirus type E antigen, in an amount effective to reduce or eliminate the neoplastic disease or to prevent its occurrence or recurrence.
    Type: Grant
    Filed: November 22, 2017
    Date of Patent: February 26, 2019
    Assignee: The United States of America, as represented by the Secretary, Department of Health and Human Services
    Inventors: Richard William Wyatt Childs, Yoshiyuki Takahashi, Sachiko Kajigaya, Nanae Harashima
  • Publication number: 20180155229
    Abstract: A submerged combustion melting system (90) includes a submerged combustion melter (100) having a housing (102) that defines a melting chamber (104) and one or more vibration damping devices (340) operatively coupled to the housing (102).
    Type: Application
    Filed: June 24, 2016
    Publication date: June 7, 2018
    Inventors: Steven James Mighton, William Wyatt Toth, Alvin Lee Miller, Bruno Andre Purnode
  • Publication number: 20180112178
    Abstract: Compositions and methods are provided for preventing or treating neoplastic disease in a mammalian subject. A composition is provided which comprises an enriched immune cell population reactive to a human endogenous retrovirus type E antigen on a tumor cell. A method of treating a neoplastic disease in a mammalian subject is provided which comprises administering to a mammalian subject a composition comprising an enriched immune cell population reactive to a human endogenous retrovirus type E antigen, in an amount effective to reduce or eliminate the neoplastic disease or to prevent its occurrence or recurrence.
    Type: Application
    Filed: November 22, 2017
    Publication date: April 26, 2018
    Applicant: The Government of the USA, as represented by the Secretary, Dept. of Health and Human Services
    Inventors: Richard William Wyatt Childs, Yoshiyuki Takahashi, Sachiko Kajigaya, Nanae Harashima
  • Patent number: 9856453
    Abstract: Compositions and methods are provided for preventing or treating neoplastic disease in a mammalian subject. A composition is provided which comprises an enriched immune cell population reactive to a human endogenous retrovirus type E antigen on a tumor cell. A method of treating a neoplastic disease in a mammalian subject is provided which comprises administering to a mammalian subject a composition comprising an enriched immune cell population reactive to a human endogenous retrovirus type E antigen, in an amount effective to reduce or eliminate the neoplastic disease or to prevent its occurrence or recurrence.
    Type: Grant
    Filed: November 20, 2014
    Date of Patent: January 2, 2018
    Assignee: The United States of America, as represented by the Secretary, Department of Health and Human Services
    Inventors: Richard William Wyatt Childs, Yoshiyuki Takahashi, Sachiko Kajigaya, Nanae Harashima
  • Patent number: 9450966
    Abstract: A method and system for verifying the integrity of virtual machines and for verifying the integrity of discrete elements of the virtual machines throughout the lifecycle of the virtual machines. A virtual machine manager capable of managing one or more virtual machine images is installed on a physical hardware platform. An integrity verification component can be communicatively coupled to the virtual machine manager and an integrity reference component so that the integrity verification component can compare digests of the virtual machine image or discrete virtual machine image elements to virtual machine integrity records accessible from the integrity reference component.
    Type: Grant
    Filed: July 24, 2008
    Date of Patent: September 20, 2016
    Assignee: KIP Sign P1 LP
    Inventors: Ronald James Forrester, William Wyatt Starnes, Frank A. Tycksen, Jr.
  • Publication number: 20160257984
    Abstract: This disclosure provides methods for preparing a sequencing library including the steps of providing a template nucleic acid sequence, dNTPs, dUTP, a primer, a polymerase, a dUTP excising enzyme, and a plurality of beads including oligonucleotide adapter sequence segments; amplifying the template nucleic acid with the polymerase, dNTPs, dUTP and random hexamer to provide a complementary nucleic acid sequence including occasional dUTPs; and excising the incorporated dUTPs with the dUTP excising enzyme to provide nicks in the complementary nucleic acid sequence to provide a sequencing library.
    Type: Application
    Filed: January 7, 2016
    Publication date: September 8, 2016
    Inventors: Paul Hardenbol, Pranav Patel, Benjamin Hindson, Paul William Wyatt, Keith Bjornson, Indira Wu, Kamila Belhocine
  • Publication number: 20150152384
    Abstract: Compositions and methods are provided for preventing or treating neoplastic disease in a mammalian subject. A composition is provided which comprises an enriched immune cell population reactive to a human endogenous retrovirus type E antigen on a tumor cell. A method of treating a neoplastic disease in a mammalian subject is provided which comprises administering to a mammalian subject a composition comprising an enriched immune cell population reactive to a human endogenous retrovirus type E antigen, in an amount effective to reduce or eliminate the neoplastic disease or to prevent its occurrence or recurrence.
    Type: Application
    Filed: November 20, 2014
    Publication date: June 4, 2015
    Inventors: RICHARD WILLIAM WYATT CHILDS, YOSHIYUKI TAKAHASHI, SACHIKO KAJIGAYA, NANAE HARASHIMA
  • Patent number: 8921050
    Abstract: Compositions and methods are provided for preventing or treating neoplastic disease in a mammalian subject. A composition is provided which comprises an enriched immune cell population reactive to a human endogenous retrovirus type E antigen on a tumor cell. A method of treating a neoplastic disease in a mammalian subject is provided which comprises administering to a mammalian subject a composition comprising an enriched immune cell population reactive to a human endogenous retrovirus type E antigen, in an amount effective to reduce or eliminate the neoplastic disease or to prevent its occurrence or recurrence.
    Type: Grant
    Filed: March 16, 2007
    Date of Patent: December 30, 2014
    Assignee: The United States of America, as represented by the Secretary, Department of Health and Human Services
    Inventors: Richard William Wyatt Childs, Yoshiyuki Takahashi, Sachiko Kajigaya, Nanae Harashima